Kirk, Thomas F. http://orcid.org/0000-0002-3458-2104
Barker, Adam J. http://orcid.org/0000-0003-2574-3081
Bodossian, Armen
Staruch, Robert http://orcid.org/0000-0003-1718-2341
Funding for this research was provided by:
Magdalen College, University of Oxford (Bellhouse Scholarship)
RCUK | Engineering and Physical Sciences Research Council (18000064)
Article History
Received: 13 June 2022
Accepted: 29 November 2022
First Online: 16 December 2022
Competing interests
: T.F.K., R.S. and Oxford University Innovation are shareholders in Vaxine Limited, a registered company in England and Wales (number 13182914), which owns the intellectual property of Vaximap. The authors declare no other conflicts of interest.